¹⁷⁷Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer

Figure 4

Anterior and posterior whole-body images of a healthy volunteer (man) at 20 min, 6, 24, 48, and 120 h after ¹⁷⁷Lu-iPSMA administration (185 MBq).